Singapore: +65-31631880 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Kenya: +254-732-300719

          

Clinical Trial News

Investigation casts doubt over trial used to support top-selling anti-clotting drug

An investigation published by The BMJ today raises new concerns about the top-selling anti-clotting drug, rivaroxaban (Xarelto).

The hidden costs of the financial conflict of interest in medicine

In a paper published in the current issue of Psychotherapy and Psychosomatics, Giovanni A.

Benzodiazepines 'do not increase dementia risk'

Past research has linked benzodiazepines - drugs used to treat anxiety and insomnia - to increased dementia risk for seniors, but a new study has found no such association.

Microreactor replaces animal testing

Researchers all over Europe are working on alternatives to animal testing that can be used to evaluate the adverse side-effects of medications. But many of these test methods still present problems.

Moderate improvements in blood glucose levels could deliver significant benefits for people with diabetes in the UK and the NHS

Sanofi, Diabetes UK and JDRF have announced the publication of IMPACT 2 in the journal Diabetic Medicine.

Royal College of Surgeons backs calls for increase in placebo surgery

A working party looking into the inclusion of placebos in surgical trials has led to a recommendation for greater use of the controversial method by the Royal College of Surgeons of England.

Results from Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure published

Jazz Pharmaceuticals plc has announced that data from the phase 3 pivotal study of defibrotide were published online in BLOOD, the Journal of the American Society of Hematology (ASH).

Myeloma UK and the Structural Genomics Consortium announce open-access collaboration to discover new drug targets for myeloma

Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to discover and characterise novel drug targets for myeloma using structural biology...



James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook